Principal, Head of Life Sciences, Global Strategy Group
KPMG in the U.S.
As a partner at KPMG, Roger leads the Life Science sector within KPMG’s Global Strategy Group, which provides strategic advice through to execution support to current and future industry leaders across the globe. Roger has 20+ years of consulting experience and specializes in strategy formulation and (value-based) strategic transformations with a particular emphasis on disruptive technology/business models and ‘Future Proofing’. He’s been the (co-)author of several recent KPMG publications (e.g. Future proofing supply chains in Life Sciences, Pharma 2030, The future of Oncology and most recently on the future outlook of the Medical Device industry, Medical Devices 2030.
Areas of Expertise: Advisory, Deal Advisory, Deal strategy, Disruptive Technology, Healthcare, Life Sciences, Management Consulting, Pharmaceuticals, Strategy and Operations, Transformation
Harvard Business School, Advanced Management Program
Stanford University Graduate School of Business, Executive Leadership
INSEAD, Advanced Management Programme
Endhoven University of Technology, MSc. Industrial Engineering & Management Science
Vrije Universiteit Amsterdam, Philosophy